{"entity":{"type":"insider","cik":"0001528826","url":"/insider/0001528826","json_url":"/insider/0001528826.json","name":"Brumm Joshua T","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":45,"n_filings":25,"first":"2015-11-13","last":"2026-06-23","span_basis":"filed_date"},"name_variants":[{"name":"Brumm Joshua T","source":"filing","n_filings":25,"first_seen":"2015-11-13","last_seen":"2026-06-23"}],"transactions":[{"id":5839764,"accession":"0001628280-26-044884","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-044884","line_url":"/filing/0001628280-26-044884#line-1","is_derivative":false,"issuer_cik":"0001253689","issuer_name":"CRESCENT BIOPHARMA, INC.","issuer_ticker":"CBIO","issuer_name_source":null,"issuer_url":"/issuer/0001253689","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42305.0,"shares_display":"42,305","price_per_share":17.99,"price_display":"17.99","price_state":"stated","total_value":761066.95,"total_display":"761,066.95","total_whole":"761,067","shares_owned_after":281212.0,"shares_owned_after_display":"281,212","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-23","scope":"insider"},{"id":2235646,"accession":"0000950170-24-030479","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000950170-24-030479","line_url":"/filing/0000950170-24-030479","is_derivative":false,"issuer_cik":"0001528826","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001528826","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66387.0,"shares_display":"66,387","price_per_share":25.669815777185292,"price_display":"25.67","price_state":"stated","total_value":1704142.06,"total_display":"1,704,142.06","total_whole":"1,704,142","shares_owned_after":564313.0,"shares_owned_after_display":"564,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-12","scope":"insider","n_lines":4},{"id":2235632,"accession":"0000950170-24-030479","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-24-030479","line_url":"/filing/0000950170-24-030479","is_derivative":false,"issuer_cik":"0001528826","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001528826","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":363343.0,"shares_display":"363,343","price_per_share":25.930413135797306,"price_display":"25.93","price_state":"stated","total_value":9421634.1,"total_display":"9,421,634.10","total_whole":"9,421,634","shares_owned_after":715490.0,"shares_owned_after_display":"715,490","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-08","filed_date":"2024-03-12","scope":"insider","n_lines":3},{"id":2081116,"accession":"0000950170-24-029616","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-029616","line_url":"/filing/0000950170-24-029616#line-1","is_derivative":false,"issuer_cik":"0001528826","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001528826","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9086.0,"shares_display":"9,086","price_per_share":25.85,"price_display":"25.85","price_state":"stated","total_value":234873.1,"total_display":"234,873.10","total_whole":"234,873","shares_owned_after":554385.0,"shares_owned_after_display":"554,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-11","scope":"insider"},{"id":2849586,"accession":"0000950170-24-024300","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950170-24-024300","line_url":"/filing/0000950170-24-024300","is_derivative":false,"issuer_cik":"0001528826","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001528826","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94480.0,"shares_display":"94,480","price_per_share":29.040204276037258,"price_display":"29.04","price_state":"stated","total_value":2743718.5,"total_display":"2,743,718.50","total_whole":"2,743,719","shares_owned_after":564885.0,"shares_owned_after_display":"564,885","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-01","scope":"insider","n_lines":3},{"id":2849571,"accession":"0000950170-24-024300","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-024300","line_url":"/filing/0000950170-24-024300#line-2","is_derivative":false,"issuer_cik":"0001528826","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001528826","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5520.0,"shares_display":"5,520","price_per_share":27.5,"price_display":"27.50","price_state":"stated","total_value":151800.0,"total_display":"151,800.00","total_whole":"151,800","shares_owned_after":563471.0,"shares_owned_after_display":"563,471","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-03-01","scope":"insider"},{"id":2848531,"accession":"0000950170-24-002280","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000950170-24-002280","line_url":"/filing/0000950170-24-002280","is_derivative":false,"issuer_cik":"0001528826","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001528826","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Officer (CEO & President)","role_mark":"O","role_mark_label":"Officer (CEO & President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":218536.0,"shares_display":"218,536","price_per_share":18.51392013215214,"price_display":"18.51","price_state":"stated","total_value":4045958.05,"total_display":"4,045,958.05","total_whole":"4,045,958","shares_owned_after":623272.0,"shares_owned_after_display":"623,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-04","filed_date":"2024-01-04","scope":"insider","n_lines":2},{"id":2848517,"accession":"0000950170-24-002280","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-002280","line_url":"/filing/0000950170-24-002280","is_derivative":false,"issuer_cik":"0001528826","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001528826","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Officer (CEO & President)","role_mark":"O","role_mark_label":"Officer (CEO & President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51183.0,"shares_display":"51,183","price_per_share":19.28290897368267,"price_display":"19.28","price_state":"stated","total_value":986957.13,"total_display":"986,957.13","total_whole":"986,957","shares_owned_after":600997.0,"shares_owned_after_display":"600,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-04","scope":"insider","n_lines":3},{"id":8255790,"accession":"0001209191-23-058327","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-058327","line_url":"/filing/0001209191-23-058327#line-1","is_derivative":false,"issuer_cik":"0001528826","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001528826","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7585.0,"shares_display":"7,585","price_per_share":10.72,"price_display":"10.72","price_state":"stated","total_value":81311.2,"total_display":"81,311.20","total_whole":"81,311","shares_owned_after":584971.0,"shares_owned_after_display":"584,971","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-11","filed_date":"2023-12-12","scope":"insider"},{"id":8155637,"accession":"0001209191-23-050169","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050169","line_url":"/filing/0001209191-23-050169#line-1","is_derivative":false,"issuer_cik":"0001528826","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001528826","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12032.0,"shares_display":"12,032","price_per_share":9.41,"price_display":"9.41","price_state":"stated","total_value":113221.12,"total_display":"113,221.12","total_whole":"113,221","shares_owned_after":233679.0,"shares_owned_after_display":"233,679","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-18","filed_date":"2023-09-20","scope":"insider"},{"id":8546995,"accession":"0001209191-23-049357","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-049357","line_url":"/filing/0001209191-23-049357#line-1","is_derivative":false,"issuer_cik":"0001528826","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001528826","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7672.0,"shares_display":"7,672","price_per_share":10.41,"price_display":"10.41","price_state":"stated","total_value":79865.52,"total_display":"79,865.52","total_whole":"79,866","shares_owned_after":245711.0,"shares_owned_after_display":"245,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-12","filed_date":"2023-09-13","scope":"insider"},{"id":8581867,"accession":"0001209191-23-036544","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-23-036544","line_url":"/filing/0001209191-23-036544#line-9","is_derivative":false,"issuer_cik":"0001528826","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001528826","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":187748.0,"shares_display":"187,748","price_per_share":12.61,"price_display":"12.61","price_state":"stated","total_value":2367502.28,"total_display":"2,367,502.28","total_whole":"2,367,502","shares_owned_after":253383.0,"shares_owned_after_display":"253,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-12","filed_date":"2023-06-12","scope":"insider"},{"id":8581859,"accession":"0001209191-23-036544","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-23-036544","line_url":"/filing/0001209191-23-036544#line-7","is_derivative":false,"issuer_cik":"0001528826","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001528826","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76582.0,"shares_display":"76,582","price_per_share":13.34,"price_display":"13.34","price_state":"stated","total_value":1021603.88,"total_display":"1,021,603.88","total_whole":"1,021,604","shares_owned_after":269771.0,"shares_owned_after_display":"269,771","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-09","filed_date":"2023-06-12","scope":"insider"},{"id":8581852,"accession":"0001209191-23-036544","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-036544","line_url":"/filing/0001209191-23-036544","is_derivative":false,"issuer_cik":"0001528826","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001528826","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61000.0,"shares_display":"61,000","price_per_share":13.224434098360655,"price_display":"13.22","price_state":"stated","total_value":806690.48,"total_display":"806,690.48","total_whole":"806,690","shares_owned_after":283960.0,"shares_owned_after_display":"283,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-12","scope":"insider","n_lines":2},{"id":8249636,"accession":"0001209191-23-018978","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-018978","line_url":"/filing/0001209191-23-018978#line-1","is_derivative":false,"issuer_cik":"0001528826","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001528826","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7318.0,"shares_display":"7,318","price_per_share":13.33,"price_display":"13.33","price_state":"stated","total_value":97548.94,"total_display":"97,548.94","total_whole":"97,549","shares_owned_after":322483.0,"shares_owned_after_display":"322,483","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-14","filed_date":"2023-03-15","scope":"insider"},{"id":6466264,"accession":"0001209191-22-060966","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-060966","line_url":"/filing/0001209191-22-060966#line-2","is_derivative":false,"issuer_cik":"0001528826","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001528826","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3322.0,"shares_display":"3,322","price_per_share":10.87,"price_display":"10.87","price_state":"stated","total_value":36110.14,"total_display":"36,110.14","total_whole":"36,110","shares_owned_after":329801.0,"shares_owned_after_display":"329,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-12","filed_date":"2022-12-13","scope":"insider"},{"id":6730063,"accession":"0001209191-22-053212","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-053212","line_url":"/filing/0001209191-22-053212#line-6","is_derivative":false,"issuer_cik":"0001528826","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001528826","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":195800.0,"shares_display":"195,800","price_per_share":12.46,"price_display":"12.46","price_state":"stated","total_value":2439668.0,"total_display":"2,439,668.00","total_whole":"2,439,668","shares_owned_after":204623.0,"shares_owned_after_display":"204,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-10","filed_date":"2022-10-11","scope":"insider"},{"id":6730053,"accession":"0001209191-22-053212","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-053212","line_url":"/filing/0001209191-22-053212#line-2","is_derivative":false,"issuer_cik":"0001528826","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001528826","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14200.0,"shares_display":"14,200","price_per_share":13.37,"price_display":"13.37","price_state":"stated","total_value":189854.0,"total_display":"189,854.00","total_whole":"189,854","shares_owned_after":204623.0,"shares_owned_after_display":"204,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-07","filed_date":"2022-10-11","scope":"insider"},{"id":6144138,"accession":"0001209191-22-018532","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-018532","line_url":"/filing/0001209191-22-018532#line-1","is_derivative":false,"issuer_cik":"0001528826","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001528826","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3384.0,"shares_display":"3,384","price_per_share":8.73,"price_display":"8.73","price_state":"stated","total_value":29542.32,"total_display":"29,542.32","total_whole":"29,542","shares_owned_after":210324.0,"shares_owned_after_display":"210,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-11","filed_date":"2022-03-14","scope":"insider"},{"id":5500030,"accession":"0001209191-21-057324","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-057324","line_url":"/filing/0001209191-21-057324#line-2","is_derivative":false,"issuer_cik":"0001528826","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001528826","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4584.0,"shares_display":"4,584","price_per_share":16.11,"price_display":"16.11","price_state":"stated","total_value":73848.24,"total_display":"73,848.24","total_whole":"73,848","shares_owned_after":99018.0,"shares_owned_after_display":"99,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-21","filed_date":"2021-09-22","scope":"insider"},{"id":5500027,"accession":"0001209191-21-057324","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-057324","line_url":"/filing/0001209191-21-057324#line-1","is_derivative":false,"issuer_cik":"0001528826","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001528826","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3425.0,"shares_display":"3,425","price_per_share":15.61,"price_display":"15.61","price_state":"stated","total_value":53464.25,"total_display":"53,464.25","total_whole":"53,464","shares_owned_after":103602.0,"shares_owned_after_display":"103,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-20","filed_date":"2021-09-22","scope":"insider"},{"id":4452497,"accession":"0001209191-17-057760","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-057760","line_url":"/filing/0001209191-17-057760#line-1","is_derivative":false,"issuer_cik":"0001513818","issuer_name":"Versartis, Inc.","issuer_ticker":"VSAR","issuer_name_source":null,"issuer_url":"/issuer/0001513818","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Officer (COO and CFO)","role_mark":"O","role_mark_label":"Officer (COO and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1326.0,"shares_display":"1,326","price_per_share":2.55,"price_display":"2.55","price_state":"stated","total_value":3381.3,"total_display":"3,381.30","total_whole":"3,381","shares_owned_after":201269.0,"shares_owned_after_display":"201,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-19","filed_date":"2017-10-23","scope":"insider"},{"id":4564183,"accession":"0001209191-17-039940","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-039940","line_url":"/filing/0001209191-17-039940#line-1","is_derivative":false,"issuer_cik":"0001513818","issuer_name":"Versartis, Inc.","issuer_ticker":"VSAR","issuer_name_source":null,"issuer_url":"/issuer/0001513818","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Officer (COO and CFO)","role_mark":"O","role_mark_label":"Officer (COO and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1421.0,"shares_display":"1,421","price_per_share":16.05,"price_display":"16.05","price_state":"stated","total_value":22807.05,"total_display":"22,807.05","total_whole":"22,807","shares_owned_after":105595.0,"shares_owned_after_display":"105,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-13","filed_date":"2017-06-14","scope":"insider"},{"id":4445696,"accession":"0001209191-17-033381","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-033381","line_url":"/filing/0001209191-17-033381#line-1","is_derivative":false,"issuer_cik":"0001513818","issuer_name":"Versartis, Inc.","issuer_ticker":"VSAR","issuer_name_source":null,"issuer_url":"/issuer/0001513818","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Officer (COO and CFO)","role_mark":"O","role_mark_label":"Officer (COO and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1263.0,"shares_display":"1,263","price_per_share":17.4,"price_display":"17.40","price_state":"stated","total_value":21976.2,"total_display":"21,976.20","total_whole":"21,976","shares_owned_after":107016.0,"shares_owned_after_display":"107,016","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-16","filed_date":"2017-05-17","scope":"insider"},{"id":4828993,"accession":"0001209191-17-015520","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-015520","line_url":"/filing/0001209191-17-015520","is_derivative":false,"issuer_cik":"0001513818","issuer_name":"Versartis, Inc.","issuer_ticker":"VSAR","issuer_name_source":null,"issuer_url":"/issuer/0001513818","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Officer (COO and CFO)","role_mark":"O","role_mark_label":"Officer (COO and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":20.935423666666665,"price_display":"20.94","price_state":"stated","total_value":628062.71,"total_display":"628,062.71","total_whole":"628,063","shares_owned_after":117440.0,"shares_owned_after_display":"117,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-24","filed_date":"2017-02-28","scope":"insider","n_lines":3},{"id":4410715,"accession":"0001209191-17-006523","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-006523","line_url":"/filing/0001209191-17-006523#line-2","is_derivative":false,"issuer_cik":"0001513818","issuer_name":"Versartis, Inc.","issuer_ticker":"VSAR","issuer_name_source":null,"issuer_url":"/issuer/0001513818","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Officer (COO and CFO)","role_mark":"O","role_mark_label":"Officer (COO and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2945.0,"shares_display":"2,945","price_per_share":13.852,"price_display":"13.85","price_state":"stated","total_value":40794.14,"total_display":"40,794.14","total_whole":"40,794","shares_owned_after":105779.0,"shares_owned_after_display":"105,779","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-30","filed_date":"2017-01-31","scope":"insider"},{"id":2142087,"accession":"0001209191-16-157040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-157040","line_url":"/filing/0001209191-16-157040#line-1","is_derivative":false,"issuer_cik":"0001513818","issuer_name":"Versartis, Inc.","issuer_ticker":"VSAR","issuer_name_source":null,"issuer_url":"/issuer/0001513818","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":990.0,"shares_display":"990","price_per_share":15.85,"price_display":"15.85","price_state":"stated","total_value":15691.5,"total_display":"15,691.50","total_whole":"15,692","shares_owned_after":64824.0,"shares_owned_after_display":"64,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-27","filed_date":"2016-12-29","scope":"insider"},{"id":3004761,"accession":"0001209191-16-154219","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-154219","line_url":"/filing/0001209191-16-154219#line-1","is_derivative":false,"issuer_cik":"0001513818","issuer_name":"Versartis, Inc.","issuer_ticker":"VSAR","issuer_name_source":null,"issuer_url":"/issuer/0001513818","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3021.0,"shares_display":"3,021","price_per_share":13.25,"price_display":"13.25","price_state":"stated","total_value":40028.25,"total_display":"40,028.25","total_whole":"40,028","shares_owned_after":65814.0,"shares_owned_after_display":"65,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-07","filed_date":"2016-12-08","scope":"insider"},{"id":2207563,"accession":"0001209191-16-128543","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-128543","line_url":"/filing/0001209191-16-128543#line-1","is_derivative":false,"issuer_cik":"0001513818","issuer_name":"Versartis, Inc.","issuer_ticker":"VSAR","issuer_name_source":null,"issuer_url":"/issuer/0001513818","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1448.0,"shares_display":"1,448","price_per_share":10.63,"price_display":"10.63","price_state":"stated","total_value":15392.24,"total_display":"15,392.24","total_whole":"15,392","shares_owned_after":58835.0,"shares_owned_after_display":"58,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-15","filed_date":"2016-06-17","scope":"insider"},{"id":2826315,"accession":"0001209191-16-122321","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-122321","line_url":"/filing/0001209191-16-122321#line-1","is_derivative":false,"issuer_cik":"0001513818","issuer_name":"Versartis, Inc.","issuer_ticker":"VSAR","issuer_name_source":null,"issuer_url":"/issuer/0001513818","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1265.0,"shares_display":"1,265","price_per_share":7.87,"price_display":"7.87","price_state":"stated","total_value":9955.55,"total_display":"9,955.55","total_whole":"9,956","shares_owned_after":60283.0,"shares_owned_after_display":"60,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-20","filed_date":"2016-05-20","scope":"insider"},{"id":2175247,"accession":"0001209191-16-088034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-088034","line_url":"/filing/0001209191-16-088034#line-1","is_derivative":false,"issuer_cik":"0001513818","issuer_name":"Versartis, Inc.","issuer_ticker":"VSAR","issuer_name_source":null,"issuer_url":"/issuer/0001513818","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":990.0,"shares_display":"990","price_per_share":12.436,"price_display":"12.44","price_state":"stated","total_value":12311.64,"total_display":"12,311.64","total_whole":"12,312","shares_owned_after":35548.0,"shares_owned_after_display":"35,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-30","filed_date":"2016-01-04","scope":"insider"},{"id":8728078,"accession":"0001209191-15-080093","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-080093","line_url":"/filing/0001209191-15-080093#line-1","is_derivative":false,"issuer_cik":"0001513818","issuer_name":"Versartis, Inc.","issuer_ticker":"VSAR","issuer_name_source":null,"issuer_url":"/issuer/0001513818","owner_cik":"0001528826","owner_name":"Brumm Joshua T","owner_display_name":"Brumm Joshua T","owner_url":"/insider/0001528826","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":9.99,"price_display":"9.99","price_state":"stated","total_value":24975.0,"total_display":"24,975.00","total_whole":"24,975","shares_owned_after":36538.0,"shares_owned_after_display":"36,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-12","filed_date":"2015-11-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":45,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":44,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":45},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001253689","name":"CRESCENT BIOPHARMA, INC.","url":"/issuer/0001253689","role":"Director, Officer (Chief Executive Officer)","n_filings":1,"first_seen":"2026-06-23","last_seen":"2026-06-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001818794","name":"Dyne Therapeutics, Inc.","url":"/issuer/0001818794","role":"Director, Officer (CEO & President)","n_filings":13,"first_seen":"2021-09-22","last_seen":"2024-03-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001513818","name":"Versartis, Inc.","url":"/issuer/0001513818","role":"Officer (COO and CFO)","n_filings":11,"first_seen":"2015-11-13","last_seen":"2017-10-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001528826","retrieved_at":"2026-08-27T08:29:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}